Why subscribe?
Get detailed, analyst quality, research reports. I am a biopharma insider who has spent decades developing drugs and have experience in multiple therapeutic areas, and across all parts of the development spectrum. I dive into the underlying science, therapeutic indication, treatment paradigm, commercial potential and various other key factors to write reports that highlight the key information you need to know for each company.
What you get
A detailed company report at least once a month
Proprietary company scoring summary - a summary of how company performs across key evaluation areas, built from my years of experience evaluating multiple types of assets and companies
Thoughts on key industry trends / interesting therapeutic modalities
Ability to email me for clarifications and questions
Ability to request specific company reports, schedule permitting
May have an additional cost depending on the nature of company and the request (e.g whether the report can be put on the platform)
Who should subscribe?
People looking for company specific research
Fund analysts looking to supercharge research
